Sudarshan Pharma

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE00TV01023
  • NSEID: SUDARSHAN
  • BSEID: 543828
INR
29.76
-1.5 (-4.8%)
BSENSE

Nov 20

BSE+NSE Vol: 12079

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003813,
    "name": "Sudarshan Pharma",
    "stock_name": "Sudarshan Pharma",
    "full_name": "Sudarshan Pharma Industries Ltd",
    "name_url": "stocks-analysis/sudarshan-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "29.76",
    "chg": -1.5,
    "chgp": "-4.8%",
    "dir": -1,
    "prev_price": "31.26",
    "mcapval": "794.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543828,
    "symbol": "SUDARSHAN",
    "ind_name": "Specialty Chemicals",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE00TV01023",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": 12079,
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/sudarshan-pharma-1003813-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sudarshan Pharma Falls 9.16% Amid Downgrade and Mixed Technical Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sudarshan-pharma-falls-916-amid-downgrade-and-mixed-technical-signals-4270242",
        "imagepath": "",
        "date": "2026-11-21 11:02:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Week opens at Rs.32.21, initial decline begins</p>\n                    <p><strong>17 Nov:</strong> Downgrade to Sell announced amid debt and earnings concerns</p>\n                    <p><strong>18 Nov:</strong> Technical momentum shifts amid mixed indicators</p>\n                    <p><strong>20 Nov:</strong> Sharp drop to Rs.29.76 closes the week down 9.16%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.32.76</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.29.76<..."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-technical-momentum-shifts-amid-mixed-indicators-4266131",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SudarshanPharma_technicaldot_4266131.png",
        "date": "2026-11-18 08:05:52",
        "description": "Sudarshan Pharma Industries Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s mixed technical indicators suggest a complex outlook for investors navigating its price movements and market positioning."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Downgraded to Sell Amid Debt Concerns and Flat Quarterly Performance",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-downgraded-to-sell-amid-debt-concerns-and-flat-quarterly-performance-4264860",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SudarshanPharma_mojoScore_4264860.png",
        "date": "2026-11-17 09:07:52",
        "description": "Sudarshan Pharma Industries Ltd, a micro-cap player in the Specialty Chemicals sector, has been downgraded from Hold to Sell by MarketsMOJO as of 16 Nov 2026. The revision reflects a deteriorating debt servicing capacity amid flat quarterly financials, despite healthy long-term growth and attractive valuation metrics. This comprehensive analysis explores the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the rating change."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-hold-by-marketsmojo-4261382",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SudarshanPharma_mojoScore_4261382.png",
        "date": "2026-11-14 10:10:28",
        "description": "Sudarshan Pharma Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 14 November 2026, providing investors with an up-to-date analysis of the company’s performance and outlook."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Locks at Lower Circuit With 7.48% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4249539",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SudarshanPharma_stocks_hitting_lower_circuit_4249539.png",
        "date": "2026-11-03 15:00:09",
        "description": "At Rs 32.53, Sudarshan Pharma Industries Ltd locked at its lower circuit limit of 7.48% on 03 Nov 2026, with persistent unfilled supply as sellers outnumbered buyers and the price froze at the floor level."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-hold-4246329",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SudarshanPharma_mojoScore_4246329.png",
        "date": "2026-11-01 10:10:33",
        "description": "Sudarshan Pharma Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 October 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 01 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Reports Strong Quarterly Growth Amid Market Volatility",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-reports-strong-quarterly-growth-amid-market-volatility-4244835",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SudarshanPharma_fintrenddot_4244835.png",
        "date": "2026-10-30 11:00:29",
        "description": "Sudarshan Pharma Industries Ltd has demonstrated a marked improvement in its financial performance for the quarter ended September 2026, signalling a positive shift in its growth trajectory. The company’s revenue and profit metrics have expanded significantly compared to previous quarters, reflecting operational efficiencies and robust demand in the specialty chemicals sector."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-hold-4231730",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SudarshanPharma_mojoScore_4231730.png",
        "date": "2026-10-21 10:10:38",
        "description": "Sudarshan Pharma Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 October 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-hold-4220826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SudarshanPharma_mojoScore_4220826.png",
        "date": "2026-10-10 10:10:35",
        "description": "Sudarshan Pharma Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 October 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 57,
    "sid": "1003813",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/sudarshan-pharma-industries-1003813"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
      "datetime": "09-Nov-2026",
      "details": "Pursuant to Regulation 30 and other applicable Regulations if any of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) we inform you that Mr. Nirav Shah has resigned as the Company Secretary and Compliance Officer of the Company with effect from 9/Nov/2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "07-Nov-2026",
      "details": "In terms of Regulation 30 read with Para A of Part A of Schedule III to the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 we hereby submit the updated Investor Presentation.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Nov-2026",
      "details": "Please find enclosed herewith the newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter and half yearly ended 30/Sept/2026 published in the following newspapers:",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has declared <strong>3%</strong> dividend, ex-date: 25 Aug 23",
          "dt": "2023-08-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has announced <strong>1:10</strong> stock split, ex-date: 22 Nov 24",
          "dt": "2024-11-22",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

09-Nov-2026 | Source : BSE

Pursuant to Regulation 30 and other applicable Regulations if any of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) we inform you that Mr. Nirav Shah has resigned as the Company Secretary and Compliance Officer of the Company with effect from 9/Nov/2026.

Announcement under Regulation 30 (LODR)-Investor Presentation

07-Nov-2026 | Source : BSE

In terms of Regulation 30 read with Para A of Part A of Schedule III to the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 we hereby submit the updated Investor Presentation.

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Nov-2026 | Source : BSE

Please find enclosed herewith the newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter and half yearly ended 30/Sept/2026 published in the following newspapers:

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Sudarshan Pharma Industries Ltd has declared 3% dividend, ex-date: 25 Aug 23

stock-summary
SPLITS

Sudarshan Pharma Industries Ltd has announced 1:10 stock split, ex-date: 22 Nov 24

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available